The investment bank maintained its stock ratings for Hologic, Cepheid, and T2 Biosystems.
The self-contained, cartridge-based test runs on the firm's GeneXpert system.
The company is using a $3 million, three-year grant to clinically validate the test, which it hopes will be the first of its kind approved by the FDA.
Sensitivity of GeneXpert MTB/RIF was better than microscopy, but low enough compared to culture to conclude that a negative Xpert result does not rule out TB in children.
The partners will jointly evaluate Globavir's PanGlob RT-PCR-based Dengue diagnostic assay.
In Nature this week: Icelandic genome sequences, approach to increase CRISPR efficiency, and more.
Testing showing "genetic incompatibilities" have led thousands of couples in Saudi Arabia to call off their weddings, the BBC reports.
Decode Genetics' ability to tell Icelanders, even ones the company hasn't sequenced, about their disease risk brings up ethical questions.
Genetic analysis of Britain's King Richard III and modern descendants of his relatives indicate breaks in the male line.